he traditional site for ventricular lead placement-the right ventricular apex (RVA), produces an abnormal pattern of ventricular depolarization, and there is growing evidence that pacing from this site is associated with detrimental functional and structural changes in the heart which might lead to an adverse clinical outcome. [1][2][3] These observations have increased interest in pacing at sites alternative to the RVA, mainly in the area of the right ventricular outflow tract (RVOT). It has been hypothesized that pacing in the RVOT, owing to its proximity to the His-bundle, results in a more physiological depolarization pattern and better hemodynamics and might reduce detrimental effects of long-term ventricular pacing. Results of a meta-analysis comparing RVA to RVOT pacing have suggested acute benefit from pacing at the RVOT. 4 However, poor definition of the outflow tract area and the non-randomized character of most trials confound the data. Longterm evaluation of the effects of chronic pacing are limited, although some mid-term observations show equivalency between apical and outflow tract pacing. 5,6 Other studies indicate that, in contrast to RVA, RVOT pacing preserves left ventricular (LV) function. 7 However, it is still not clear whether RVOT pacing provides better long-term outcome than RVA pacing.In this study we investigated RVOT pacing in comparison to RVA pacing in patients with standard indications for permanent ventricular pacing and preserved LV systolic function to determine whether RVOT pacing would provide better all-cause and cardiovascular survival.
MethodsThe present study was a single-center randomized study performed in a tertiary care university hospital. The first patient was enrolled on 7 th September 1995 and the last patient on 24 th November 1997. After the 10-year follow-up visit the long-term survival in the studied population was evaluated.
PatientsPatients were eligible for the study if they were at least 21 years old, had preserved LV ejection fraction (LVEF) There were no differences in the all-cause or cardiovascular mortality between the pacing sites after adjustment for age, gender, arterial hypertension, atrial fibrillation, New York Heart Association class and left ventricular end-diastolic diameter.
Conclusions:The RVOT provides no additional benefit in terms of long-term survival over RVA pacing. (Circ J